| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 03/12/2002 | US6355652 Drugs for sodium channel regulators and antiarrythmia agents |
| 03/07/2002 | WO2002018368A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 03/07/2002 | WO2002018361A2 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | US20020028826 HMG-CoA reductase inhibitors and method |
| 03/07/2002 | US20020028813 Isoquinoline inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose) polymerase (PARP); treat tissue damage from necrosis or apoptosis, ischemia or reperfusion injury, stroke, senescence diseases |
| 03/07/2002 | US20020028803 Controlling cell apoptosis |
| 03/07/2002 | US20020028760 Nervous system disorders; hypotensive agents; incontinence |
| 03/07/2002 | CA2420869A1 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | CA2420673A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 03/06/2002 | EP1183255A1 Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 03/06/2002 | EP1070062B1 Oxidation process using tempo |
| 03/05/2002 | US6353099 Substituted ureas as cell adhesion inhibitors |
| 03/05/2002 | US6352999 Drugs for nervous system disorders, parkinson's disease and antidepressants |
| 03/05/2002 | CA2111955C Novel tetracyclic compound |
| 02/28/2002 | WO2002016325A1 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |
| 02/28/2002 | WO2001066524A3 Intermediates useful for the synthesis of huperzine a |
| 02/28/2002 | WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/27/2002 | EP1181935A2 Agent for treating mental disorders associated with cerebrovascular disorders |
| 02/27/2002 | EP1181335A1 Extended rhodamine compounds useful as fluorescent labels |
| 02/27/2002 | CN1337960A Piperdine and piperazine derivatives as inhibitors of the ABETA fibril formation |
| 02/26/2002 | US6350759 Dihydro- and tetrahydro-quinoline compounds |
| 02/26/2002 | US6350749 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 02/21/2002 | WO2002014279A1 New aporphine esters and their use in therapy |
| 02/21/2002 | WO2002013827A1 Process for the preparation of dinapsoline |
| 02/21/2002 | WO2002013824A1 Cyclopentyl modulators of chemokine receptor activity |
| 02/21/2002 | US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 02/21/2002 | CA2417807A1 Process for the preparation of dinapsoline |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/19/2002 | US6348588 Method of cleaving a nucleic acid bulge |
| 02/14/2002 | WO2002012194A1 Phenantridine derivatives and their use as anti-telomerase agent |
| 02/14/2002 | WO2002005616A8 Novel 6-phenylphenanthridines |
| 02/14/2002 | US20020019540 Conformationally constrained compounds as pharmaceutical agents |
| 02/14/2002 | US20020019531 Indoles |
| 02/14/2002 | US20020019400 Compounds useful for inhibition of farnesyl protein transferase |
| 02/13/2002 | EP1179533A2 Salt of naphthyridine carboxylic acid derivative |
| 02/13/2002 | CN1335772A Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males |
| 02/13/2002 | CN1335292A Hairyleaf peudoyingzhaosu C as one compound with antineoplastic activity and its serial analogs |
| 02/12/2002 | CA2174105C Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/12/2002 | CA2024399C Compounds |
| 02/07/2002 | WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 02/07/2002 | WO2001030333A3 Tissue factor antagonists and methods of use thereof |
| 02/07/2002 | US20020016337 Heterocyclic analgesic compounds and methods of use thereof |
| 02/06/2002 | EP1177174A1 Hydroxamic and carboxylic acid derivatives |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/31/2002 | WO2001014328A3 Substituted ureas as cell adhesion inhibitors |
| 01/31/2002 | US20020013325 Useful as glycoprotein IIb/IIIa antagonists for prophylaxis thrombosis, therapy of atheroschlerosis, arterioschlerosis, acute myocardial infarction, chronic stable angina, unstable angina, transient ischemic attacks and strokes |
| 01/30/2002 | EP1175206A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives |
| 01/30/2002 | EP0946513B1 Derivatives of 6-fluorophenanthridine for liquid crystal mixtures |
| 01/30/2002 | CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/30/2002 | CN1332962A Process for prepairng weedicide imidazolinone compound |
| 01/29/2002 | CA1341335C 9-amino-1, 4 ethano-1, 2, 3, 4-tetrahydroacridine and related compounds, intermediates and a process for the preparation thereof an their use as medicaments |
| 01/24/2002 | WO2002006240A1 Substituted 4,9-dihydrocyclopenta[imn] phenanthridine-5-ones, derivatives thereof and their uses |
| 01/24/2002 | WO2002006239A1 Phenanthridine n-oxides |
| 01/24/2002 | WO2002006238A1 Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines |
| 01/24/2002 | WO2002005616A1 Novel 6-phenylphenanthridines |
| 01/24/2002 | WO2001058875A3 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
| 01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
| 01/23/2002 | EP1173519A1 Novel carbopyronine fluorescence dyes |
| 01/17/2002 | US20020007065 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 01/17/2002 | US20020006933 Method for treating sexual dysfunction with apomorphine at specified plasma concentration levels |
| 01/17/2002 | US20020006927 Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses |
| 01/17/2002 | DE10005302A1 Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 01/16/2002 | EP1172418A2 Dye compounds having a terminal hydroxy, carboxylic acid/ester or amino group |
| 01/16/2002 | EP1172360A1 Neurotrophin potentiators |
| 01/16/2002 | EP1171444A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 01/16/2002 | EP1171440A1 Substituted-3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 01/16/2002 | CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 01/10/2002 | US20020004601 Cognition activators; antidepressants |
| 01/09/2002 | CN1330638A Substituted benzo (de) isoquinoline-1,3-diones |
| 01/08/2002 | US6337344 Anticoagulants and enzyme inhibitors for cardiovascular disorders |
| 01/08/2002 | CA2251545C Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors |
| 01/03/2002 | US20020002176 Apomorphine and norapomorphine N-glucuronides, O-sulfates, O-glucuronides, N-sulfates, O-phosphates and N-phosphates, esters, ethers, and N-alkyls; sexual disorders and Parkinson's disease; bioavailability; side effect reduction |
| 01/03/2002 | US20020002170 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
| 01/02/2002 | EP1167354A2 Racemic huperzine A |
| 01/02/2002 | EP1167353A1 Morphan derivatives or salts thereof and medicinal compositions containing the same |
| 01/02/2002 | EP1165694A1 4,7-dichlororhodamine dyes useful as molecular probes |
| 01/02/2002 | CN1329607A Substituted benzopyran analogs for treatment of inflammation |
| 01/02/2002 | CN1329493A Methods and compositions for restoring conformational stability of a protein of the p53 family |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 12/27/2001 | WO2001064645A3 Derivatives of quinoline as alpha-2 antagonists |
| 12/26/2001 | CN1328549A Substituted benzo [de] isoquinoline-1,3-diones |
| 12/25/2001 | CA2068590C Process and intermediates for the preparation of spiro¬isoquinoline-4(1h),3'-pyrrolidine|-1,2',3,5'(2h)-tetrones which are useful as aldose reductase inhibitors |
| 12/25/2001 | CA2053640C Quinoline derivatives |
| 12/20/2001 | WO2001096311A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 12/20/2001 | US20010053783 Central nervous system disorders |
| 12/20/2001 | CA2412979A1 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 12/19/2001 | EP1163226A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 12/19/2001 | EP0912573B1 Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents |
| 12/19/2001 | EP0781281B1 Beta-carboline derivatives as melatonin agonists, methods for their preparation and their use as drugs |
| 12/19/2001 | EP0639080B1 Non-azo naphthalimide dyes and use as alkylating agents |
| 12/18/2001 | USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
| 12/13/2001 | WO2001042219A3 Novel substituted phenanthridinones and methods of use thereof |
| 12/13/2001 | US20010051633 E.g.,N-((4-amino-3-nitrophenoxy)ethyl)-1,2,3,4-tetrahydro -isoquinoline; stroke; antiischemic agents; CNS trauma, hyperglycemic agents; surgery; neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis |
| 12/13/2001 | US20010051620 Tricyclic protein kinase inhibitors |
| 12/12/2001 | EP1161434A1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 12/12/2001 | EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists |
| 12/12/2001 | EP1161412A1 Nuclear receptor arylating compounds |
| 12/12/2001 | EP0723540B1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 12/12/2001 | EP0723539B1 Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 12/12/2001 | EP0723538B1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |